OncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 08, 2017 21:06 pm UTC| Business
Demcizumab and Tarextumab Randomized Phase 2 Data Expected 1H 2017 Anti-TIGIT IND Accepted; GITRL-Fc IND Expected 1H 2017 OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PT ...
OncoMed Pharmaceuticals Announces Fourth Quarter and Full Year 2016 Financial Results
Mar 08, 2017 21:06 pm UTC| Business
Demcizumab and Tarextumab Randomized Phase 2 Data Expected 1H 2017 Anti-TIGIT IND Accepted; GITRL-Fc IND Expected 1H 2017 OncoMed Management to Host Conference Call/Webcast this Afternoon at 4:30 p.m. ET/1:30 p.m. PT ...
Sunnova Selects Enphase Energy, Inc. as Preferred Inverter Supplier
Mar 08, 2017 21:06 pm UTC| Business
PETALUMA, Calif. and HOUSTON, March 08, 2017 -- Enphase Energy, Inc.(NASDAQ:ENPH), a global energy technology company, and Sunnova Energy Corp., a market leader in residential solar services, today announced an...
Sunnova Selects Enphase Energy, Inc. as Preferred Inverter Supplier
Mar 08, 2017 21:06 pm UTC| Business
PETALUMA, Calif. and HOUSTON, March 08, 2017 -- Enphase Energy, Inc.(NASDAQ:ENPH), a global energy technology company, and Sunnova Energy Corp., a market leader in residential solar services, today announced an...
Image Sensing Systems Announces Chad Stelzig as President and Chief Executive Officer
Mar 08, 2017 21:06 pm UTC| Business
ST. PAUL, Minn., March 08, 2017 -- Image Sensing Systems, Inc. (NASDAQ:ISNS) today announced that the board has appointed Chad Stelzig as permanent president and chief executive officer (CEO), effective immediately. Mr....
Image Sensing Systems Announces Chad Stelzig as President and Chief Executive Officer
Mar 08, 2017 21:06 pm UTC| Business
ST. PAUL, Minn., March 08, 2017 -- Image Sensing Systems, Inc. (NASDAQ:ISNS) today announced that the board has appointed Chad Stelzig as permanent president and chief executive officer (CEO), effective immediately. Mr....
Points International Ltd. Reports Fourth Quarter and Full Year 2016 Financial Results
Mar 08, 2017 21:06 pm UTC| Business
– Full Year Revenue of $321.8 Million Increases 9% and Gross Profit of $43.3 Million Increases 2% Year-over-year – Full Year Net Income of $3.5 Million, before the impact of an impairment loss of $5.0 Million, Decreases...